Andrew Fein
Stock Analyst at HC Wainwright & Co.
(3.40)
# 937
Out of 4,876 analysts
631
Total ratings
43.74%
Success rate
4.41%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $45.71 | +31.26% | 8 | Jun 26, 2025 | |
| BIIB Biogen | Reiterates: Buy | $187 | $126.92 | +47.34% | 21 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $22.21 | +44.08% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $443.40 | +24.04% | 27 | Jun 23, 2025 | |
| INSM Insmed | Maintains: Buy | $90 → $120 | $101.74 | +17.95% | 15 | Jun 11, 2025 | |
| PEPG PepGen | Maintains: Buy | $14 → $8 | $1.28 | +525.00% | 13 | May 29, 2025 | |
| SVRA Savara | Downgrades: Neutral | $6 → $2 | $2.21 | -9.50% | 13 | May 29, 2025 | |
| LQDA Liquidia | Maintains: Buy | $29 → $35 | $12.83 | +172.80% | 14 | May 28, 2025 | |
| VIGL Vigil Neuroscience | Downgrades: Neutral | $14 → $8 | $7.95 | +0.63% | 14 | May 27, 2025 | |
| PRTA Prothena Corporation | Maintains: Buy | $30 → $14 | $6.18 | +126.54% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $11.84 | +195.61% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $2.45 | +471.43% | 15 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $21.08 | +255.79% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $68 | $29.83 | +127.96% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $1.50 | +566.67% | 10 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $10.05 | +278.11% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $16 | $6.50 | +146.15% | 20 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $13.51 | +85.05% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $14.50 | +120.77% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $9.66 | +210.56% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $425 | $284.09 | +49.60% | 15 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $9.21 | +73.72% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $7.80 | +207.69% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $135 | $128.15 | +5.35% | 18 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.09 | +474.16% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $20.62 | +84.29% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.79 | +186.74% | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $126.71 | +32.59% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $2.02 | +246.53% | 13 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $1.21 | +809.09% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.26 | +693.65% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $7.03 | +212.94% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $2 | $0.80 | +150.31% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $11.50 | +73.91% | 14 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $2.16 | +455.56% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $4.88 | +166.39% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.90 | +39.24% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $2.98 | +671.81% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.48 | +913.51% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $53.18 | +59.83% | 16 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $21.89 | +59.89% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4 | $7.38 | -45.80% | 17 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $8.02 | +835.16% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $26.07 | +187.69% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.79 | +919.11% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $1.52 | +360.53% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $6.96 | +43.68% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $40 | $2.63 | +1,420.91% | 3 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.94 | +15,823.57% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $15.90 | +277.36% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $3.87 | +287.60% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $1.75 | +2,182.45% | 3 | Mar 16, 2022 |
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $45.71
Upside: +31.26%
Biogen
Jun 26, 2025
Reiterates: Buy
Price Target: $187
Current: $126.92
Upside: +47.34%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $22.21
Upside: +44.08%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $443.40
Upside: +24.04%
Insmed
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $101.74
Upside: +17.95%
PepGen
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $1.28
Upside: +525.00%
Savara
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $2.21
Upside: -9.50%
Liquidia
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $12.83
Upside: +172.80%
Vigil Neuroscience
May 27, 2025
Downgrades: Neutral
Price Target: $14 → $8
Current: $7.95
Upside: +0.63%
Prothena Corporation
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $6.18
Upside: +126.54%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $11.84
Upside: +195.61%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $2.45
Upside: +471.43%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $21.08
Upside: +255.79%
May 12, 2025
Maintains: Buy
Price Target: $72 → $68
Current: $29.83
Upside: +127.96%
May 9, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $1.50
Upside: +566.67%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $10.05
Upside: +278.11%
May 9, 2025
Maintains: Buy
Price Target: $12 → $16
Current: $6.50
Upside: +146.15%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $13.51
Upside: +85.05%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $14.50
Upside: +120.77%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $9.66
Upside: +210.56%
May 5, 2025
Reiterates: Buy
Price Target: $425
Current: $284.09
Upside: +49.60%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $9.21
Upside: +73.72%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $7.80
Upside: +207.69%
May 2, 2025
Reiterates: Buy
Price Target: $135
Current: $128.15
Upside: +5.35%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $2.09
Upside: +474.16%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $20.62
Upside: +84.29%
Apr 28, 2025
Reiterates: Buy
Price Target: $8
Current: $2.79
Upside: +186.74%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $126.71
Upside: +32.59%
Apr 4, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $2.02
Upside: +246.53%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $1.21
Upside: +809.09%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $1.26
Upside: +693.65%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $7.03
Upside: +212.94%
Mar 17, 2025
Downgrades: Neutral
Price Target: $12 → $2
Current: $0.80
Upside: +150.31%
Mar 14, 2025
Reiterates: Buy
Price Target: $20
Current: $11.50
Upside: +73.91%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $2.16
Upside: +455.56%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $4.88
Upside: +166.39%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $7.90
Upside: +39.24%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $2.98
Upside: +671.81%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.48
Upside: +913.51%
Mar 3, 2025
Reiterates: Buy
Price Target: $85
Current: $53.18
Upside: +59.83%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $21.89
Upside: +59.89%
Feb 26, 2025
Reiterates: Neutral
Price Target: $4
Current: $7.38
Upside: -45.80%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $8.02
Upside: +835.16%
Jan 13, 2025
Reiterates: Buy
Price Target: $75
Current: $26.07
Upside: +187.69%
Aug 8, 2024
Reiterates: Buy
Price Target: $8
Current: $0.79
Upside: +919.11%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $1.52
Upside: +360.53%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $6.96
Upside: +43.68%
Feb 13, 2023
Maintains: Buy
Price Target: $100 → $40
Current: $2.63
Upside: +1,420.91%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.94
Upside: +15,823.57%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $15.90
Upside: +277.36%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $3.87
Upside: +287.60%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $1.75
Upside: +2,182.45%